RecruitingNot ApplicableNCT03802851

HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer


Sponsor

University of Kansas Medical Center

Enrollment

30 participants

Start Date

Sep 19, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

To determine if holmium laser enucleation of the prostate (HoLEP) for the treatment of lower urinary tract symptoms (LUTS) and/or urinary retention alters the treatment course for patients concurrently diagnosed with prostate cancer.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether performing a minimally invasive prostate procedure called HoLEP (a laser surgery that removes excess prostate tissue to improve urine flow) before radiation therapy can safely reduce urinary problems in men with prostate cancer who also have significant difficulty urinating. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with prostate cancer - You have bothersome urinary symptoms: a high symptom score, a large amount of urine remaining in your bladder after urinating, or you require a catheter to urinate - You are scheduled to receive radiation therapy for prostate cancer **You may NOT be eligible if...** - You do not have significant urinary symptoms or retention - You have already received radiation therapy for prostate cancer - You have conditions that make the HoLEP procedure unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREHolmium Laser Enucleation of Prostate (HoLEP)

Holmium laser enucleation of the prostate (HoLEP) is a surgical treatment use for men with bothersome lower urinary tract symptoms (LUTS) to improve their LUTS. During the procedure a thin telescope-like instrument is inserted into the urethra. The high-powered laser is then inserted through this instrument and used to carefully remove the excess prostate tissue that is causing obstruction of the urethra and contributing to the patient's lower urinary tract symptoms.


Locations(1)

University of Kansas Health System

Kansas City, Kansas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03802851


Related Trials